欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号PT/H/1153/002
药品名称Cloreto de Potássio + Cloreto de Sódio Kabi
活性成分
    • Potassium chloride 3.0 mg
    • Sodium chloride 9.0 mg
剂型Solution for infusion
上市许可持有人Freseniuns Kabi Pharma Portugal, Lda
参考成员国 - 产品名称Portugal (PT)
互认成员国 - 产品名称
    • Belgium (BE)
      KCl 0.3% w/v + NaCl 0.9% w/v Fresenius Kabi, oplossing voor infusie
    • United Kingdom (Northern Ireland) (XI)
    • Ireland (IE)
    • France (FR)
    • Spain (ES)
    • Italy (IT)
    • Poland (PL)
      Kalii chloridum 0,15% + Natrii chloridum 0.9% Kabi
    • Latvia (LV)
      Potassium Chloride/ Sodium Chloride Fresenius 3 mg/9 mg/ml šķīdums infūzijām
    • Lithuania (LT)
      Potassium Chloride/Sodium Chloride Fresenius 3 mg/9 mg/ml infuzinis tirpalas
    • Estonia (EE)
      POTASSIUM CHLORIDE/SODIUM CHLORIDE FRESENIUS
许可日期2014/06/25
最近更新日期2025/10/13
药物ATC编码
    • B05BB01 electrolytes
申请类型
  • TypeLevel1：Abridged
  • TypeLevel2：Initial Application
  • TypeLevel3：Generic
  • TypeLevel4：Chemical Substance
  • TypeLevel5：Prescription Only
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase